Kenvue Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Kenvue Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-29 | 2025-03-30 | 2024-12-29 | 2024-09-29 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-10-01 | 2023-07-02 | 2023-04-02 |
|---|---|---|---|---|---|---|---|---|---|---|
| cash flows from operating activities | ||||||||||
| net income | 420,000,000 | 322,000,000 | 293,000,000 | 383,000,000 | 58,000,000 | 296,000,000 | 327,000,000 | 577,000,000 | 430,000,000 | 330,000,000 |
| adjustments to reconcile net income to cash flows from operating activities | ||||||||||
| depreciation and amortization | 142,000,000 | 136,000,000 | 150,000,000 | 182,000,000 | 141,000,000 | 149,000,000 | 174,000,000 | 153,000,000 | 148,000,000 | 152,000,000 |
| stock-based compensation | 37,000,000 | 44,000,000 | 54,000,000 | 58,000,000 | 61,000,000 | 81,000,000 | 113,000,000 | 2,000,000 | 38,000,000 | 35,000,000 |
| deferred income taxes | -14,000,000 | -13,000,000 | -40,000,000 | -40,000,000 | -201,000,000 | -4,000,000 | 14,000,000 | -283,000,000 | -12,000,000 | 167,000,000 |
| impairment charges | 0 | 0 | ||||||||
| losses on investments | ||||||||||
| other | 17,000,000 | 16,000,000 | 2,000,000 | 17,000,000 | 45,000,000 | 5,000,000 | 17,000,000 | -23,000,000 | ||
| net changes in assets and liabilities | ||||||||||
| trade receivables | 48,000,000 | -99,000,000 | 125,000,000 | -110,000,000 | -109,000,000 | -124,000,000 | 141,000,000 | -42,000,000 | -78,000,000 | 23,000,000 |
| inventories | -51,000,000 | -66,000,000 | 169,000,000 | 62,000,000 | 14,000,000 | -63,000,000 | 74,000,000 | 132,000,000 | 126,000,000 | 17,000,000 |
| other current and non-current assets | 53,000,000 | 59,000,000 | -46,000,000 | -6,000,000 | 90,000,000 | -55,000,000 | -11,000,000 | 77,000,000 | -482,000,000 | -13,000,000 |
| accounts payable and accrued liabilities | 123,000,000 | -14,000,000 | 37,000,000 | -336,000,000 | -56,000,000 | -181,000,000 | ||||
| employee-related obligations | -7,000,000 | 3,000,000 | ||||||||
| accrued taxes on income | -91,000,000 | 62,000,000 | -70,000,000 | 53,000,000 | -71,000,000 | 27,000,000 | -479,000,000 | 272,000,000 | ||
| other liabilities | -56,000,000 | -22,000,000 | 25,000,000 | -12,000,000 | -13,000,000 | 52,000,000 | 11,000,000 | 28,000,000 | -62,000,000 | -189,000,000 |
| net cash flows from operating activities | 621,000,000 | 428,000,000 | 793,000,000 | 249,000,000 | 440,000,000 | 287,000,000 | 950,000,000 | 674,000,000 | 742,000,000 | 802,000,000 |
| capex | -88,000,000 | -179,000,000 | -132,000,000 | -59,000,000 | -90,000,000 | -153,000,000 | -223,000,000 | -114,000,000 | -77,000,000 | -55,000,000 |
| free cash flows | 533,000,000 | 249,000,000 | 661,000,000 | 190,000,000 | 350,000,000 | 134,000,000 | 727,000,000 | 560,000,000 | 665,000,000 | 747,000,000 |
| cash flows used in investing activities | ||||||||||
| purchases of property, plant, and equipment | -88,000,000 | -179,000,000 | -132,000,000 | -59,000,000 | -90,000,000 | -153,000,000 | -223,000,000 | -114,000,000 | -77,000,000 | -55,000,000 |
| other investing activities | -2,000,000 | 12,000,000 | 6,000,000 | 3,000,000 | 5,000,000 | 1,000,000 | -49,000,000 | |||
| net cash flows used in investing activities | -90,000,000 | -167,000,000 | -132,000,000 | -56,000,000 | -85,000,000 | -152,000,000 | -265,000,000 | -105,000,000 | -77,000,000 | -41,000,000 |
| cash flows used in financing activities | ||||||||||
| (repayments of) proceeds from commercial paper program, net of issuance cost | ||||||||||
| proceeds from issuance of senior notes, net of issuance cost | 0 | 0 | ||||||||
| repayment of senior notes | 0 | -750,000,000 | ||||||||
| dividends paid | -393,000,000 | -392,000,000 | -393,000,000 | -393,000,000 | -383,000,000 | -383,000,000 | -383,000,000 | |||
| purchase of treasury stock | -64,000,000 | -63,000,000 | ||||||||
| other financing activities | 56,000,000 | 27,000,000 | 35,000,000 | 45,000,000 | -5,000,000 | -12,000,000 | -77,000,000 | |||
| net cash flows used in financing activities | -548,000,000 | -310,000,000 | -587,000,000 | -162,000,000 | -383,000,000 | -726,000,000 | ||||
| effect of exchange rate changes on cash and cash equivalents | 30,000,000 | 36,000,000 | -61,000,000 | 12,000,000 | 18,000,000 | -12,000,000 | ||||
| cash and cash equivalents, beginning of period | 0 | 1,070,000,000 | 0 | 0 | 0 | 0 | ||||
| net increase in cash and cash equivalents | 320,000,000 | |||||||||
| cash and cash equivalents, end of period | 13,000,000 | 1,057,000,000 | 13,000,000 | 43,000,000 | 320,000,000 | -169,000,000 | ||||
| proceeds from commercial paper program, net of issuance cost | 868,000,000 | -101,000,000 | 208,000,000 | -110,000,000 | 160,000,000 | 77,000,000 | -245,000,000 | |||
| net decrease in cash and cash equivalents | -13,000,000 | |||||||||
| losses (gains) on investments | ||||||||||
| transfer of funds to j&j pursuant to the facility agreement | 0 | 0 | ||||||||
| proceeds from j&j upon repayment of the facility agreement | 0 | 0 | ||||||||
| (costs associated with) proceeds from sale of assets | ||||||||||
| proceeds from (payments of) loans and notes payables | -7,000,000 | 1,000,000 | ||||||||
| proceeds from kenvue ipo | 0 | 0 | ||||||||
| distribution to j&j in connection with the separation | 0 | 0 | ||||||||
| net transfers to j&j | ||||||||||
| supplemental disclosures of cash flow information | ||||||||||
| net cash paid for income taxes | ||||||||||
| cash paid for interest | ||||||||||
| employee related obligations | -2,000,000 | 2,000,000 | 5,000,000 | -6,000,000 | 10,000,000 | |||||
| proceeds from sale of assets | 7,000,000 | 0 | 0 | 14,000,000 | ||||||
| purchases of treasury shares | -23,000,000 | 0 | -91,000,000 | |||||||
| impairments | 99,000,000 | |||||||||
| cash flows (used in) from financing activities | ||||||||||
| payments of loans and notes payables | ||||||||||
| net transfers from (to) j&j | ||||||||||
| net cash flows (used in) from financing activities | -326,000,000 | |||||||||
| effect of exchange rate changes on cash and cash equivalents and restricted cash | -36,000,000 | 6,000,000 | ||||||||
| cash and cash equivalents and restricted cash, beginning of period | 1,382,000,000 | 1,231,000,000 | ||||||||
| net increase in cash and cash equivalents and restricted cash | -227,000,000 | 8,155,000,000 | ||||||||
| cash and cash equivalents and restricted cash, end of period | 1,155,000,000 | 9,386,000,000 | ||||||||
| accounts payable | 159,000,000 | -98,000,000 | 383,000,000 | -54,000,000 | ||||||
| accrued liabilities | 340,000,000 | -52,000,000 | 724,000,000 | 52,000,000 | ||||||
| cash flows from (used in) financing activities | ||||||||||
| (payments of) proceeds from loans and notes payables | ||||||||||
| net transfer from (to) j&j | ||||||||||
| (proceeds from) payments of loans and notes payable | ||||||||||
| net transfer to j&j | ||||||||||
| other investing | ||||||||||
| (payments of) proceeds from loans and notes payable | -2,000,000 | -12,000,000 | ||||||||
| net transfer to the parent | 12,000,000 | -286,000,000 | ||||||||
| other financing | ||||||||||
| proceeds from long-term debt, net of issuance costs | 7,686,000,000 | |||||||||
| net cash flows from (used in) financing activities | 7,388,000,000 |
We provide you with 20 years of cash flow statements for Kenvue stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kenvue stock. Explore the full financial landscape of Kenvue stock with our expertly curated income statements.
The information provided in this report about Kenvue stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.